Santana, Fernanda P. R; Silva, Rafael C. da; Ponci, Vitor; Pinheiro, Aruana J. M. C. R; Olivo, Clarice Rosa 
; Caperuto, Luciana C; Arantes-Costa, Fernanda M; Claudio, Samuel R; Ribeiro, Daniel A; Tibério, Iolanda Fátima Lopes Calvo
Source: Biochemical pharmacology. Unidade: FM
Subjects: ASMA, CAMUNDONGOS, PNEUMONIA, ÁCIDOS CARBOXÍLICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANTANA, Fernanda P. R et al. Dehydrodieugenol improved lung inflammation in an asthma model by inhibiting the STAT3/SOCS3 and MAPK pathways. Biochemical pharmacology, v. 180, 2020Tradução . . Disponível em: https://doi.org/10.1016/j.bcp.2020.114175. Acesso em: 14 nov. 2024.APA
Santana, F. P. R., Silva, R. C. da, Ponci, V., Pinheiro, A. J. M. C. R., Olivo, C. R., Caperuto, L. C., et al. (2020). Dehydrodieugenol improved lung inflammation in an asthma model by inhibiting the STAT3/SOCS3 and MAPK pathways. Biochemical pharmacology, 180. doi:10.1016/j.bcp.2020.114175NLM
Santana FPR, Silva RC da, Ponci V, Pinheiro AJMCR, Olivo CR, Caperuto LC, Arantes-Costa FM, Claudio SR, Ribeiro DA, Tibério IFLC. Dehydrodieugenol improved lung inflammation in an asthma model by inhibiting the STAT3/SOCS3 and MAPK pathways [Internet]. Biochemical pharmacology. 2020 ; 180[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.bcp.2020.114175Vancouver
Santana FPR, Silva RC da, Ponci V, Pinheiro AJMCR, Olivo CR, Caperuto LC, Arantes-Costa FM, Claudio SR, Ribeiro DA, Tibério IFLC. Dehydrodieugenol improved lung inflammation in an asthma model by inhibiting the STAT3/SOCS3 and MAPK pathways [Internet]. Biochemical pharmacology. 2020 ; 180[citado 2024 nov. 14 ] Available from: https://doi.org/10.1016/j.bcp.2020.114175
